Associate Professor, Behavioral Science, University of Kentucky College of Medicine

Psychiatry

Dr. Michelle R. Lofwall, MD

Michelle R. Lofwall, MD is an expert in the field of Psychiatry. Michelle R. Lofwall is also a published MD. She has 27 publication published. The most recent publication is: Safety of oral dronabinol during opioid withdrawal in humans.

Publications

Safety of oral dronabinol during opioid withdrawal in humans.
States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.
Challenges of the capacity evaluation for the consultation-liaison psychiatrist.
Buprenorphine Diversion and Misuse in Outpatient Practice.
Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.
Determination of Oxycodone, Noroxycodone and Oxymorphone by High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry in Human Matrices: ...
Abuse liability and reinforcing efficacy of oral tramadol in humans.
Effects of the NK(1) antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.
Characteristics of older opioid maintenance patients.
Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass ...
Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
Experimentally-induced spontaneous opiate withdrawal: relationship to cigarette craving and expired air carbon monoxide.
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Changing profile of abused substances by older persons entering treatment.
Pharmacy willingness to partner with office-based opioid dependence treatment providers in conducting random buprenorphine pill counts.
Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.
Physical dependence potential of daily tramadol dosing in humans.
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.
Efficacy of continuing medical education to reduce the risk of buprenorphine diversion.
Clinical challenges in managing buprenorphine diversion.
Understanding and treating opioid addiction in a patient with cancer pain.
Individual and network factors associated with non-fatal overdose among rural Appalachian drug users.

Schools

Rosalind Franklin University of Medicine and Science Chicago Medical School

Doctors Specialties

Psychiatry

Accepted Insurances

Education

Johns Hopkins University
Rosalind Franklin University of Medicine and Science

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Mark H. Pugh, DO This Doctor is OpenDoctor Recommended.
	Dr. Teresa A. Oropilla-Kiefer, MD This Doctor is OpenDoctor Recommended.
	Dr. Vincent J. Mullen II, MD This Doctor is OpenDoctor Recommended.
	Dr. Javali B. Aroon, MD This Doctor is OpenDoctor Recommended.
	Dr. Getulio V. Tovar, MD
	Dr. Douglas D. Ruth, MD This Doctor is OpenDoctor Recommended.
	Dr. Martha M. Foster, MD This Doctor is OpenDoctor Recommended.
	Dr. Ruhel Boparai, MD This Doctor is OpenDoctor Recommended.
	Dr. Carol E. Fisk-Owais, MD
	Dr. Manuel R. Hernandez, MD